Stock-Split Watch: Is Quantum Computing Inc. [QUBT] Next?

Quantum Computing Inc. (QUBT) has rallied more than 170% over the past year after a December NASA Goddard prime contract for its Dirac-3 quantum optimizer produced a one-day 53% jump; Lake Street initiated coverage with a buy and a $24 target (~35% upside). Management is unlikely to enact a stock split — shares peaked near $27 and trade around $10 — and the company remains unprofitable, rendering the P/E metric irrelevant. Trailing price-to-sales is roughly 2,566x per Morningstar (versus 127x for IonQ and 247x for D-Wave), suggesting QUBT is richly valued and that investors seeking quantum exposure may prefer peers or an ETF to reduce risk.

Analysis

Market structure: Incumbent hardware providers and diversified vehicles (IONQ, QBTS) are the likely beneficiaries of a reallocation away from single-contract narrative stocks; capital is chasing a small supply of investable, revenue-generating quantum names which amplifies idiosyncratic moves in thinly traded tickers. Rich valuations on QUBT compress its pricing power versus peers—buyers now pay a liquidity/option premium rather than fundamental multiple support—so share-price moves will be driven more by headlines and float dynamics than steady demand growth.

Risk assessment: Near-term (days) volatility is the dominant risk; medium-term (weeks–months) the biggest tail is equity dilution to fund operations or missed milestone revenue recognition, any of which could halve market cap. Long-term (12–36 months) outcomes hinge on repeatable revenue and IP monetization; hidden dependencies include contractor concentration (a few public contracts) and software/hardware delivery mismatch that can blow out cash burn. Key catalysts are follow-on NASA/R&D orders (60–180 days) and next quarterly cash-burn/revenue prints.

Trade implications: Favor relative-value exposure—allocate modest real capital to IONQ and QBTS while trimming or shorting QUBT; prefer 3–6 month option exposure to capture binary outcomes. Size positions small (1–3% portfolio) and use defined-risk options (buy puts or calls 20–30% OTM) to limit dilution/volatility risk; take profits on 30–50% moves or cut losses at 15%. Rebalance after next two quarterly reports.

Contrarian angles: The market may be over-discounting QUBT’s ability to convert contracts into recurring revenue, yet it also underestimates short-squeeze mechanics in low-float names—both mispricings coexist. Historical parallels (small-cap defense/space contractors post-contract announcement) show either rapid collapse after failed follow-ons or multi-bagger re-rates after scale; trade with tight, time-boxed option horizons to capture that asymmetry.

Key Decisions for Investors

• Initiate a tactical short on QUBT sized to 1–1.5% of portfolio via 90-day puts at ~25% OTM (approx. $7.50 strike if underlying ≈ $10); set a max loss per position at 15% of portfolio allocation and plan to exit if QUBT trades above $15.
• Establish a relative-value trade: long IONQ equal to 2% of portfolio funded by a 1.5% short in QUBT (equal notional). Target a 30% relative outperformance within 3–6 months; trim if IONQ outperforms by >30% or cut if underperforms by >15%.
• Buy 6-month IONQ 20% OTM calls sized to 0.5–1% of portfolio to gain convex upside to real commercial adoption; sell 1/2 position on a 50% gain or roll if implied vol >60% and time premium decays unfavorably.
• Redeploy single-stock QUBT exposure into QBTS (ETF) within 30 days up to 2–4% portfolio weight to reduce idiosyncratic risk; if QUBT’s next quarterly report shows no material NASA-related revenue (line-item < $1m) within 60 days, increase QUBT short exposure to 3%.